E. Jason Abel

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

Mohamad E. Allaf, Se-Eun Kim, Viraj A. Master et al. · The Lancet Oncology · 2024 · 82 citations · Full text

Medicine, Oncology, Surgery +10

Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer

Matthew Truong, Jon Slezak, Chee Paul Lin et al. · Cancer · 2013 · 76 citations · Full text

Medicine, Oncology, Urology +16

Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma

José A. Karam, Xiu-Ying Zhang, Pheroze Tamboli et al. · European Urology · 2010 · 59 citations

Medicine, Cancer Biology, Oncology +11

The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study

India Anderson-Carter, Natasza Posielski, Jinn‐Ing Liou et al. · Urologic Oncology Seminars and Original Investigations · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer

Michael L. Blute, Timothy Rushmer, Fangfang Shi et al. · The Journal of Urology · 2015 · 16 citations · Full text

Medicine, Surgery, Urology +17